|
DE
|
|
94-3156479
|
||
(State or Other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
||
|
|
|
|
|
1 Wayside Road
|
||||
Burlington,
|
|
MA
|
|
01803
|
(Address of principal executive offices)
|
|
|
|
(Zip Code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common stock, par value $0.001
|
NUAN
|
Nasdaq Stock Market LLC
|
Large Accelerated Filer
|
☒
|
|
Accelerated Filer
|
☐
|
Non-accelerated Filer
|
☐
|
|
Smaller Reporting Company
|
☐
|
|
|
|
Emerging Growth Company
|
☐
|
|
|
|
|
|
Page
|
Item 1.
|
|
Condensed Consolidated Financial Statements:
|
|
|
|
|
Consolidated Statements of Operations for the three months ended December 31, 2019 and 2018
|
|
|
|
|
Consolidated Statements of Comprehensive Income (Loss) for the three months ended December 31, 2019 and 2018
|
|
|
|
|
Consolidated Balance Sheets at December 31, 2019 and September 30, 2019
|
|
|
|
|
Consolidated Statements of Stockholders’ Equity for the three months ended December 31, 2019 and 2018
|
|
|
|
|
Consolidated Statements of Cash Flows for the three months ended December 31, 2019 and 2018
|
|
|
|
|
Notes to Condensed Consolidated Financial Statements
|
|
|
Item 2.
|
|
|
||
Item 3.
|
|
|
||
Item 4.
|
|
|
||
|
||||
Item 1.
|
|
|
||
Item 1A.
|
|
|
||
Item 2.
|
|
|
||
Item 3.
|
|
|
||
Item 4.
|
|
|
||
Item 5.
|
|
|
||
Item 6.
|
|
|
||
|
||||
|
||||
Certifications
|
|
|
|
Three Months Ended December 31,
|
||||||
|
2019
|
|
2018
|
||||
|
(Unaudited)
(In thousands, except per share amounts)
|
||||||
Revenues:
|
|
|
|
||||
Hosting and professional services
|
$
|
230,477
|
|
|
$
|
227,717
|
|
Product and licensing
|
125,180
|
|
|
115,889
|
|
||
Maintenance and support
|
62,576
|
|
|
76,069
|
|
||
Total revenues
|
418,233
|
|
|
419,675
|
|
||
Cost of revenues:
|
|
|
|
||||
Hosting and professional services
|
135,790
|
|
|
136,598
|
|
||
Product and licensing
|
34,178
|
|
|
32,405
|
|
||
Maintenance and support
|
7,794
|
|
|
7,761
|
|
||
Amortization of intangible assets
|
6,627
|
|
|
7,356
|
|
||
Total cost of revenues
|
184,389
|
|
|
184,120
|
|
||
Gross profit
|
233,844
|
|
|
235,555
|
|
||
Operating expenses:
|
|
|
|
||||
Research and development
|
56,553
|
|
|
46,866
|
|
||
Sales and marketing
|
66,472
|
|
|
67,370
|
|
||
General and administrative
|
38,314
|
|
|
43,466
|
|
||
Amortization of intangible assets
|
12,549
|
|
|
13,842
|
|
||
Acquisition-related costs, net
|
1,167
|
|
|
2,601
|
|
||
Restructuring and other charges, net
|
6,683
|
|
|
14,641
|
|
||
Total operating expenses
|
181,738
|
|
|
188,786
|
|
||
Income from operations
|
52,106
|
|
|
46,769
|
|
||
Other (expense) income:
|
|
|
|
||||
Interest income
|
2,186
|
|
|
2,554
|
|
||
Interest expense
|
(23,815
|
)
|
|
(32,266
|
)
|
||
Other expense, net
|
(12,040
|
)
|
|
(1,176
|
)
|
||
Income before income taxes
|
18,437
|
|
|
15,881
|
|
||
(Benefit) provision for income taxes
|
(36,440
|
)
|
|
2,000
|
|
||
Net income from continuing operations
|
54,877
|
|
|
13,881
|
|
||
Net (loss) income from discontinued operations
|
(6,192
|
)
|
|
5,209
|
|
||
Net income
|
$
|
48,685
|
|
|
$
|
19,090
|
|
|
|
|
|
||||
Net income (loss) per common share - basic:
|
|
|
|
||||
Continuing operations
|
$
|
0.19
|
|
|
$
|
0.05
|
|
Discontinued operations
|
(0.02
|
)
|
|
0.02
|
|
||
Total net income per basic common share
|
$
|
0.17
|
|
|
$
|
0.07
|
|
|
|
|
|
||||
Net income (loss) per common share - diluted:
|
|
|
|
||||
Continuing operations
|
$
|
0.19
|
|
|
$
|
0.05
|
|
Discontinued operations
|
(0.02
|
)
|
|
0.02
|
|
||
Total net income per diluted common share
|
$
|
0.17
|
|
|
$
|
0.07
|
|
|
|
|
|
||||
Weighted average common shares outstanding:
|
|
|
|
||||
Basic
|
284,130
|
|
|
287,796
|
|
||
Diluted
|
289,453
|
|
|
292,359
|
|
|
Three Months Ended December 31,
|
||||||
|
2019
|
|
2018
|
||||
|
(Unaudited)
|
||||||
|
(In thousands)
|
||||||
Net income
|
$
|
48,685
|
|
|
$
|
19,090
|
|
Other comprehensive income (loss):
|
|
|
|
||||
Foreign currency translation adjustment
|
4,424
|
|
|
(8,302
|
)
|
||
Cerence Spin-off
|
12,331
|
|
|
—
|
|
||
Pension adjustments
|
2,007
|
|
|
(360
|
)
|
||
Unrealized loss on marketable securities
|
(32
|
)
|
|
(2
|
)
|
||
Total other comprehensive income (loss), net
|
18,730
|
|
|
(8,664
|
)
|
||
Comprehensive income
|
$
|
67,415
|
|
|
$
|
10,426
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
||||||||||||||||
|
Common Stock
|
|
Additional Paid-In Capital
|
|
Treasury Stock
|
|
Other Comprehensive Loss
|
|
Accumulated Deficit
|
|
Noncontrolling Interests
|
|
Total Stockholders' Equity
|
||||||||||||||||||||
|
Shares
|
|
Amount
|
|
|
Shares
|
|
Amount
|
|
|
|
|
|||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||
Balance at September 30, 2019
|
289,680
|
|
|
$
|
290
|
|
|
$
|
2,597,889
|
|
|
3,751
|
|
|
$
|
(16,788
|
)
|
|
$
|
(132,773
|
)
|
|
$
|
(293,612
|
)
|
|
$
|
18,144
|
|
|
$
|
2,173,150
|
|
Cerence spin-off
|
—
|
|
|
—
|
|
|
(922,567
|
)
|
|
—
|
|
|
—
|
|
|
12,331
|
|
|
—
|
|
|
(18,144
|
)
|
|
(928,380
|
)
|
|||||||
Issuance of common stock under employee stock plans
|
5,582
|
|
|
6
|
|
|
50
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
56
|
|
|||||||
Cancellation of restricted stock, and repurchase of common stock at cost for employee tax withholding
|
(1,942
|
)
|
|
(2
|
)
|
|
(33,127
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(33,129
|
)
|
|||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
66,182
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
66,182
|
|
|||||||
Repurchase and retirement of common stock
|
(5,694
|
)
|
|
(6
|
)
|
|
(92,438
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(92,444
|
)
|
|||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
48,685
|
|
|
—
|
|
|
48,685
|
|
|||||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,399
|
|
|
—
|
|
|
—
|
|
|
6,399
|
|
|||||||
Balance at December 31, 2019
|
287,626
|
|
|
$
|
288
|
|
|
$
|
1,615,989
|
|
|
3,751
|
|
|
$
|
(16,788
|
)
|
|
$
|
(114,043
|
)
|
|
$
|
(244,927
|
)
|
|
$
|
—
|
|
|
$
|
1,240,519
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
||||||||||||||||
|
Common Stock
|
|
Additional Paid-In Capital
|
|
Treasury Stock
|
|
Other Comprehensive Loss
|
|
Accumulated Deficit
|
|
Noncontrolling Interests
|
|
Total Stockholders' Equity
|
||||||||||||||||||||
|
Shares
|
|
Amount
|
|
|
Shares
|
|
Amount
|
|
|
|
|
|||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||
Balance at September 30, 2018
|
291,504
|
|
|
$
|
291
|
|
|
$
|
2,597,693
|
|
|
3,751
|
|
|
$
|
(16,788
|
)
|
|
$
|
(122,863
|
)
|
|
$
|
(740,837
|
)
|
|
$
|
—
|
|
|
$
|
1,717,496
|
|
Adoption of ASC 606
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
233,415
|
|
|
—
|
|
|
233,415
|
|
|||||||
Issuance of common stock under employee stock plans
|
5,153
|
|
|
6
|
|
|
(6
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Cancellation of restricted stock, and repurchase of common stock at cost for employee tax withholding
|
(1,730
|
)
|
|
(2
|
)
|
|
(27,518
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(27,520
|
)
|
|||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
83,478
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
83,478
|
|
|||||||
Repurchase and retirement of common stock
|
(4,892
|
)
|
|
(5
|
)
|
|
(75,151
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(75,156
|
)
|
|||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,090
|
|
|
—
|
|
|
19,090
|
|
|||||||
Other comprehensive loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(8,664
|
)
|
|
—
|
|
|
—
|
|
|
(8,664
|
)
|
|||||||
Balance at December 31, 2018
|
290,035
|
|
|
$
|
290
|
|
|
$
|
2,578,496
|
|
|
3,751
|
|
|
$
|
(16,788
|
)
|
|
$
|
(131,527
|
)
|
|
$
|
(488,332
|
)
|
|
$
|
—
|
|
|
$
|
1,942,139
|
|
|
|
Three Months Ended December 31,
|
||||||
|
2019
|
|
2018
|
||||
|
(Unaudited)
(In thousands)
|
||||||
Cash flows from operating activities:
|
|
|
|
||||
Net income from continuing operations
|
$
|
54,877
|
|
|
$
|
13,881
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation
|
10,183
|
|
|
13,679
|
|
||
Amortization
|
19,176
|
|
|
21,198
|
|
||
Stock-based compensation
|
31,233
|
|
|
29,497
|
|
||
Non-cash interest expense
|
12,744
|
|
|
12,298
|
|
||
Deferred tax benefit
|
(40,288
|
)
|
|
(2,089
|
)
|
||
Loss on extinguishment of debt
|
15,000
|
|
|
—
|
|
||
Other
|
(749
|
)
|
|
312
|
|
||
Changes in operating assets and liabilities, excluding effects of acquisitions:
|
|
|
|
||||
Accounts receivable
|
(19,242
|
)
|
|
(15,254
|
)
|
||
Prepaid expenses and other assets
|
30,118
|
|
|
(25,926
|
)
|
||
Accounts payable
|
(1,346
|
)
|
|
12,503
|
|
||
Accrued expenses and other liabilities
|
(71,741
|
)
|
|
(19,317
|
)
|
||
Deferred revenue
|
26,895
|
|
|
31,881
|
|
||
Net cash provided by operating activities - continuing operations
|
66,860
|
|
|
72,663
|
|
||
Net cash (used in) provided by operating activities - discontinued operations
|
(13,307
|
)
|
|
27,228
|
|
||
Net cash provided by operating activities
|
53,553
|
|
|
99,891
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Capital expenditures
|
(14,204
|
)
|
|
(12,220
|
)
|
||
Purchases of marketable securities and other investments
|
(86,699
|
)
|
|
(47,502
|
)
|
||
Proceeds from sales and maturities of marketable securities and other investments
|
82,588
|
|
|
45,678
|
|
||
Other
|
1,272
|
|
|
(1,447
|
)
|
||
Net cash used in investing activities
|
(17,043
|
)
|
|
(15,491
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Repayment and redemption of debt
|
(313,500
|
)
|
|
—
|
|
||
Net distribution from Cerence upon the spin-off
|
139,090
|
|
|
—
|
|
||
Payments for repurchase of common stock
|
(92,444
|
)
|
|
(75,156
|
)
|
||
Payments for taxes related to net share settlement of equity awards
|
(29,958
|
)
|
|
(31,651
|
)
|
||
Other financing activities
|
(725
|
)
|
|
(696
|
)
|
||
Net cash used in financing activities
|
(297,537
|
)
|
|
(107,503
|
)
|
||
Effects of exchange rate changes on cash and cash equivalents
|
1,524
|
|
|
391
|
|
||
Net decrease in cash and cash equivalents
|
(259,503
|
)
|
|
(22,712
|
)
|
||
Cash and cash equivalents at beginning of period
|
560,961
|
|
|
315,963
|
|
||
Cash and cash equivalents at end of period
|
$
|
301,458
|
|
|
$
|
293,251
|
|
•
|
identification of the contract, or contracts, with a customer;
|
•
|
identification of the performance obligations in the contract, including whether they are distinct within the context of the contract;
|
•
|
determination of the transaction price, including the constraint on variable consideration;
|
•
|
allocation of the transaction price to the performance obligations in the contract; and
|
•
|
recognition of revenue when, or as, performance obligations are satisfied.
|
•
|
the pricing of standalone sales (in the instances where available);
|
•
|
the pricing established by management when setting prices for deliverables that are intended to be sold on a standalone basis;
|
•
|
contractually stated prices for deliverables that are intended to be sold on a standalone basis; and
|
•
|
other pricing factors, such as the geographical region in which the products are sold and expected discounts based on the customer size and type.
|
|
For the Three Months Ended December 31, 2019
|
||||||||||||||
|
Hosting and professional services
|
|
Product and licensing
|
|
Maintenance and support
|
|
Total
|
||||||||
Healthcare
|
$
|
144,983
|
|
|
$
|
91,957
|
|
|
$
|
33,594
|
|
|
$
|
270,534
|
|
Enterprise
|
77,637
|
|
|
31,736
|
|
|
29,011
|
|
|
138,384
|
|
||||
Other
|
7,857
|
|
|
1,487
|
|
|
(29
|
)
|
|
9,315
|
|
||||
Total revenues
|
$
|
230,477
|
|
|
$
|
125,180
|
|
|
$
|
62,576
|
|
|
$
|
418,233
|
|
|
For the Three Months Ended December 31, 2018
|
||||||||||||||
|
Hosting and professional services
|
|
Product and licensing
|
|
Maintenance and support
|
|
Total
|
||||||||
Healthcare
|
$
|
133,515
|
|
|
$
|
93,029
|
|
|
$
|
45,321
|
|
|
$
|
271,865
|
|
Enterprise
|
78,542
|
|
|
20,279
|
|
|
30,631
|
|
|
129,452
|
|
||||
Other
|
15,660
|
|
|
2,581
|
|
|
117
|
|
|
18,358
|
|
||||
Total revenues
|
$
|
227,717
|
|
|
$
|
115,889
|
|
|
$
|
76,069
|
|
|
$
|
419,675
|
|
|
Contract assets
|
||
Balance as of October 1, 2019
|
$
|
167,324
|
|
Revenues recognized but not billed
|
56,797
|
|
|
Amounts reclassified to accounts receivable
|
(74,501
|
)
|
|
Balance at December 31, 2019
|
$
|
149,620
|
|
|
Deferred revenue
|
||
Balance as of October 1, 2019
|
$
|
348,006
|
|
Amounts bill but not recognized
|
274,795
|
|
|
Revenue recognized
|
(248,892
|
)
|
|
Balance at December 31, 2019
|
$
|
373,909
|
|
|
Within One Year
|
|
Two to Four Years
|
|
Greater than Four Years
|
|
Total
|
||||||||
Total revenue
|
$
|
721,808
|
|
|
$
|
912,306
|
|
|
$
|
90,206
|
|
|
$
|
1,724,320
|
|
|
Three Months Ended December 31,
|
||||||||||||||
|
2019
|
|
2018
|
||||||||||||
|
Automotive
|
|
Imaging
|
|
Automotive
|
|
Total
|
||||||||
Major line items constituting net income of discontinued operations:
|
|
|
|
|
|
|
|
||||||||
Revenue
|
$
|
—
|
|
|
$
|
51,995
|
|
|
$
|
73,979
|
|
|
$
|
125,974
|
|
Cost of revenue
|
—
|
|
|
12,004
|
|
|
29,318
|
|
|
41,322
|
|
||||
Research and development
|
—
|
|
|
5,516
|
|
|
21,462
|
|
|
26,978
|
|
||||
Sales and marketing
|
—
|
|
|
18,190
|
|
|
7,989
|
|
|
26,179
|
|
||||
General and administrative
|
—
|
|
|
1,231
|
|
|
583
|
|
|
1,814
|
|
||||
Amortization of intangible assets
|
—
|
|
|
3,914
|
|
|
3,132
|
|
|
7,046
|
|
||||
Acquisition-related costs, net
|
—
|
|
|
(386
|
)
|
|
235
|
|
|
(151
|
)
|
||||
Restructuring and other charges, net
|
7,386
|
|
|
8,460
|
|
|
8,440
|
|
|
16,900
|
|
||||
Other
|
—
|
|
|
—
|
|
|
16
|
|
|
16
|
|
||||
(Loss) income from discontinued operations before income taxes
|
(7,386
|
)
|
|
3,066
|
|
|
2,804
|
|
|
5,870
|
|
||||
Provision (benefit) for income taxes
|
1,194
|
|
|
1,675
|
|
|
(1,014
|
)
|
|
661
|
|
||||
Net (loss) income from discontinued operations
|
$
|
(6,192
|
)
|
|
$
|
1,391
|
|
|
$
|
3,818
|
|
|
$
|
5,209
|
|
|
|
|
|
|
|
|
|
||||||||
Supplemental information:
|
|
|
|
|
|
|
|
||||||||
Depreciation
|
$
|
—
|
|
|
$
|
294
|
|
|
$
|
2,136
|
|
|
$
|
2,430
|
|
Amortization
|
—
|
|
|
4,926
|
|
|
5,534
|
|
|
10,460
|
|
||||
Stock compensation
|
—
|
|
|
2,102
|
|
|
4,843
|
|
|
6,945
|
|
||||
Capital expenditures
|
—
|
|
|
—
|
|
|
780
|
|
|
780
|
|
|
September 30,
2019 |
||
Major classes of assets of discontinued operations:
|
|
||
Accounts receivable, net
|
$
|
67,928
|
|
Prepaid expenses and other current assets
|
23,930
|
|
|
Land, building and equipment, net
|
20,113
|
|
|
Goodwill
|
1,115,568
|
|
|
Intangible assets, net
|
65,561
|
|
|
Other assets
|
35,366
|
|
|
Total assets
|
$
|
1,328,466
|
|
|
|
||
Major classes of liabilities of discontinued operations:
|
|
||
Accounts payable
|
$
|
14,039
|
|
Accrued expenses and other current liabilities
|
27,429
|
|
|
Deferred revenue
|
353,700
|
|
|
Other liabilities
|
21,603
|
|
|
Total liabilities
|
$
|
416,771
|
|
|
Healthcare
|
|
Enterprise
|
|
Other
|
|
Total
|
||||||||
Balance as of September 30, 2019
|
$
|
1,435,144
|
|
|
$
|
679,903
|
|
|
$
|
12,849
|
|
|
$
|
2,127,896
|
|
Effect of foreign currency translation
|
1,961
|
|
|
2,283
|
|
|
109
|
|
|
4,353
|
|
||||
Balance at December 31, 2019
|
$
|
1,437,105
|
|
|
$
|
682,186
|
|
|
$
|
12,958
|
|
|
$
|
2,132,249
|
|
|
Intangible
Assets
|
||
Balance as of September 30, 2019
|
$
|
291,371
|
|
Amortization
|
(19,176
|
)
|
|
Effect of foreign currency translation
|
664
|
|
|
Balance at December 31, 2019
|
$
|
272,859
|
|
Derivatives Not Designated as Hedges
|
|
Balance Sheet Classification
|
|
Fair Value
|
||||||
|
December 31,
2019 |
|
September 30,
2019 |
|||||||
Foreign currency forward contracts
|
|
Prepaid expenses and other current assets
|
|
$
|
—
|
|
|
$
|
597
|
|
Foreign currency forward contracts
|
|
Accrued expenses and other current liabilities
|
|
(90
|
)
|
|
(327
|
)
|
|
|
Income Statement Classification
|
|
Three Months Ended December 31,
|
||||||
Derivatives Not Designated as Hedges
|
|
Income (Loss) Recognized
|
|
2019
|
|
2018
|
||||
Foreign currency forward contracts
|
|
Other income (expense), net
|
|
$
|
585
|
|
|
$
|
(1,730
|
)
|
•
|
Level 1: Quoted prices for identical assets or liabilities in active markets.
|
•
|
Level 2: Observable inputs other than those described as Level 1.
|
•
|
Level 3: Unobservable inputs that are supportable by little or no market activities and are based on significant assumptions and estimates.
|
|
December 31, 2019
|
||||||||||||||
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Money market funds(a)
|
$
|
174,658
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
174,658
|
|
Time deposits(b)
|
—
|
|
|
115,286
|
|
|
—
|
|
|
115,286
|
|
||||
Commercial paper, $79,063 at cost(b)
|
—
|
|
|
79,584
|
|
|
—
|
|
|
79,584
|
|
||||
Corporate notes and bonds, $31,175 at cost(b)
|
—
|
|
|
31,213
|
|
|
—
|
|
|
31,213
|
|
||||
Foreign currency exchange contracts(b)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Total assets at fair value
|
$
|
174,658
|
|
|
$
|
226,083
|
|
|
$
|
—
|
|
|
$
|
400,741
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
Foreign currency exchange contracts(b)
|
$
|
—
|
|
|
$
|
(90
|
)
|
|
$
|
—
|
|
|
$
|
(90
|
)
|
Contingent acquisition payments(c)
|
—
|
|
|
—
|
|
|
(2,493
|
)
|
|
(2,493
|
)
|
||||
Total liabilities at fair value
|
$
|
—
|
|
|
$
|
(90
|
)
|
|
$
|
(2,493
|
)
|
|
$
|
(2,583
|
)
|
|
September 30, 2019
|
||||||||||||||
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Money market funds(a)
|
$
|
217,861
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
217,861
|
|
Time deposits(b)
|
—
|
|
|
115,913
|
|
|
—
|
|
|
115,913
|
|
||||
Commercial paper, $77,089 at cost(b)
|
—
|
|
|
77,494
|
|
|
—
|
|
|
77,494
|
|
||||
Corporate notes and bonds, $37,504 at cost(b)
|
—
|
|
|
37,566
|
|
|
—
|
|
|
37,566
|
|
||||
Foreign currency exchange contracts(b)
|
—
|
|
|
597
|
|
|
—
|
|
|
597
|
|
||||
Total assets at fair value
|
$
|
217,861
|
|
|
$
|
231,570
|
|
|
$
|
—
|
|
|
$
|
449,431
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
Foreign currency exchange contracts(b)
|
$
|
—
|
|
|
$
|
(327
|
)
|
|
$
|
—
|
|
|
$
|
(327
|
)
|
Contingent acquisition payments(c)
|
—
|
|
|
—
|
|
|
(2,925
|
)
|
|
(2,925
|
)
|
||||
Total liabilities at fair value
|
$
|
—
|
|
|
$
|
(327
|
)
|
|
$
|
(2,925
|
)
|
|
$
|
(3,252
|
)
|
(a)
|
Money market funds and time deposits with original maturity of 90 days or less are included within cash and cash equivalents in the consolidated balance sheets and are valued at quoted market prices in active markets.
|
(b)
|
Time deposits, commercial paper, corporate notes and bonds, and foreign currency exchange contracts are recorded at fair market values, which are determined based on the most recent observable inputs for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable. Time deposits are generally for terms of one year or less. Commercial paper and corporate notes and bonds generally mature within three years and had a weighted average maturity of 0.43 years as of December 31, 2019 and 0.53 years as of September 30, 2019.
|
(c)
|
The fair values of our contingent consideration arrangements were determined using either the option pricing model with Monte Carlo simulation or the probability-weighted discounted cash flow method.
|
|
Three Months Ended December 31,
|
||||||
2019
|
|
2018
|
|||||
Balance at beginning of period
|
$
|
2,550
|
|
|
$
|
4,000
|
|
Earn-out liabilities established at time of acquisition
|
—
|
|
|
—
|
|
||
Payments and foreign currency translation
|
(57
|
)
|
|
(21
|
)
|
||
Adjustments to fair value included in acquisition-related costs, net
|
—
|
|
|
—
|
|
||
Balance at end of period
|
$
|
2,493
|
|
|
$
|
3,979
|
|
|
December 31,
2019 |
|
September 30,
2019 |
||||
Compensation
|
$
|
67,808
|
|
|
$
|
119,412
|
|
Cost of revenue related liabilities
|
40,007
|
|
|
58,012
|
|
||
Accrued interest payable
|
3,681
|
|
|
19,302
|
|
||
Consulting and professional fees
|
14,504
|
|
|
20,401
|
|
||
Sales and marketing incentives
|
1,316
|
|
|
2,692
|
|
||
Sales and other taxes payable
|
6,295
|
|
|
8,089
|
|
||
Facility-related liabilities
|
—
|
|
|
2,503
|
|
||
Operating lease obligations
|
38,115
|
|
|
—
|
|
||
Other
|
14,602
|
|
|
19,159
|
|
||
Total
|
$
|
186,328
|
|
|
$
|
249,570
|
|
|
Personnel
|
|
Facilities
|
|
Total
|
||||||
Balance at September 30, 2019
|
$
|
3,587
|
|
|
$
|
3,622
|
|
|
$
|
7,209
|
|
ASC 842 implementation (a)
|
—
|
|
|
11,674
|
|
|
11,674
|
|
|||
Restructuring charges, net
|
2,913
|
|
|
1,135
|
|
|
4,048
|
|
|||
Non-cash adjustment
|
—
|
|
|
1,263
|
|
|
1,263
|
|
|||
Cash payments
|
(5,026
|
)
|
|
(982
|
)
|
|
(6,008
|
)
|
|||
Balance at December 31, 2019
|
$
|
1,474
|
|
|
$
|
16,712
|
|
|
$
|
18,186
|
|
|
Three Months Ended December 31,
|
||||||||||||||||||||||||||||||||||||||
|
2019
|
|
2018
|
||||||||||||||||||||||||||||||||||||
|
Personnel
|
|
Facilities
|
|
Total Restructuring
|
|
Other Charges
|
|
Total
|
|
Personnel
|
|
Facilities
|
|
Total Restructuring
|
|
Other Charges
|
|
Total
|
||||||||||||||||||||
Healthcare
|
$
|
1,276
|
|
|
$
|
1,527
|
|
|
$
|
2,803
|
|
|
$
|
—
|
|
|
$
|
2,803
|
|
|
$
|
1,479
|
|
|
$
|
127
|
|
|
$
|
1,606
|
|
|
$
|
—
|
|
|
$
|
1,606
|
|
Enterprise
|
1,304
|
|
|
505
|
|
|
1,809
|
|
|
—
|
|
|
1,809
|
|
|
2,551
|
|
|
13
|
|
|
2,564
|
|
|
—
|
|
|
2,564
|
|
||||||||||
Other
|
—
|
|
|
(365
|
)
|
|
(365
|
)
|
|
—
|
|
|
(365
|
)
|
|
1,030
|
|
|
—
|
|
|
1,030
|
|
|
2,507
|
|
|
3,537
|
|
||||||||||
Corporate
|
333
|
|
|
(532
|
)
|
|
(199
|
)
|
|
2,635
|
|
|
2,436
|
|
|
1,153
|
|
|
(290
|
)
|
|
863
|
|
|
6,071
|
|
|
6,934
|
|
||||||||||
Total
|
$
|
2,913
|
|
|
$
|
1,135
|
|
|
$
|
4,048
|
|
|
$
|
2,635
|
|
|
$
|
6,683
|
|
|
$
|
6,213
|
|
|
$
|
(150
|
)
|
|
$
|
6,063
|
|
|
$
|
8,578
|
|
|
$
|
14,641
|
|
|
|
December 31,
2019 |
|
September 30,
2019 |
||||
5.625% Senior Notes due 2026, net of deferred issuance costs of $4.3 million and $4.5 million, respectively. Effective interest rate 5.625%.
|
$
|
495,672
|
|
|
$
|
495,518
|
|
6.000% Senior Notes due 2024, net of deferred issuance costs of $1.5 million. Effective interest rate 6.000%.
|
—
|
|
|
298,529
|
|
||
1.000% Convertible Debentures due 2035, net of unamortized discount of $85.0 million and $91.6 million, respectively, and deferred issuance costs of $3.9 million and $4.3 million, respectively. Effective interest rate 5.622%.
|
587,531
|
|
|
580,639
|
|
||
2.750% Convertible Debentures due 2031. Effective interest rate 7.432%.
|
46,568
|
|
|
46,568
|
|
||
1.250% Convertible Debentures due 2025, net of unamortized discount of $68.8 million and $71.6 million, respectively, and deferred issuance costs of $3.0 million and $3.1 million, respectively. Effective interest rate 5.578%.
|
278,201
|
|
|
275,257
|
|
||
1.500% Convertible Debentures due 2035, net of unamortized discount of $20.1 million and $22.7 million, respectively, and deferred issuance costs of $0.7 million and $0.8 million, respectively. Effective interest rate 5.394%.
|
243,106
|
|
|
240,406
|
|
||
Deferred issuance costs related to our Revolving Credit Facility
|
(428
|
)
|
|
(511
|
)
|
||
Total debt
|
1,650,650
|
|
|
1,936,406
|
|
||
Less: current portion (a)
|
—
|
|
|
(1,142,870
|
)
|
||
Total long-term debt
|
$
|
1,650,650
|
|
|
$
|
793,536
|
|
Fiscal Year
|
|
Convertible Debentures(1)
|
|
Senior Notes
|
|
Total
|
||||||
2020
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
2021
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
2022
|
|
310,463
|
|
|
—
|
|
|
310,463
|
|
|||
2023
|
|
676,488
|
|
|
—
|
|
|
676,488
|
|
|||
2024
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Thereafter
|
|
350,000
|
|
|
500,000
|
|
|
850,000
|
|
|||
Total before unamortized discount
|
|
1,336,951
|
|
|
500,000
|
|
|
1,836,951
|
|
|||
Less: unamortized discount and issuance costs
|
|
(181,545
|
)
|
|
(4,756
|
)
|
|
(186,301
|
)
|
|||
Total long-term debt
|
|
$
|
1,155,406
|
|
|
$
|
495,244
|
|
|
$
|
1,650,650
|
|
(1)
|
Pursuant to the terms of each convertible instrument, holders have the right to redeem the debt on specific dates prior to maturity. The repayment schedule above assumes that payment is due on the next redemption date after December 31, 2019.
|
|
Three Months Ended December 31,
|
||||||
2019
|
|
2018
|
|||||
Numerator:
|
|
|
|
||||
Net income from continuing operations
|
$
|
54,877
|
|
|
$
|
13,881
|
|
Net (loss) income from discontinued operations
|
(6,192
|
)
|
|
5,209
|
|
||
Net income
|
$
|
48,685
|
|
|
$
|
19,090
|
|
|
|
|
|
||||
Denominator:
|
|
|
|
||||
Weighted average common shares outstanding — basic
|
284,130
|
|
|
287,796
|
|
||
Dilutive effect of employee stock compensation plans
|
5,323
|
|
|
4,563
|
|
||
Weighted average common shares outstanding — diluted
|
289,453
|
|
|
292,359
|
|
||
|
|
|
|
||||
Net income (loss) per common share - basic:
|
|
|
|
||||
Continuing operations
|
$
|
0.19
|
|
|
$
|
0.05
|
|
Discontinued operations
|
(0.02
|
)
|
|
0.02
|
|
||
Total net income per basic common share
|
$
|
0.17
|
|
|
$
|
0.07
|
|
|
|
|
|
||||
Net income (loss) per common share - diluted:
|
|
|
|
||||
Continuing operations
|
$
|
0.19
|
|
|
$
|
0.05
|
|
Discontinued operations
|
(0.02
|
)
|
|
0.02
|
|
||
Total net income per diluted common share
|
$
|
0.17
|
|
|
$
|
0.07
|
|
|
|
|
|
||||
Anti-dilutive equity instruments excluded from the calculation
|
1,336
|
|
|
1,962
|
|
||
Contingently issuable awards excluded from the calculation
|
2,932
|
|
|
2,076
|
|
|
Three Months Ended December 31,
|
||||||
2019
|
|
2018
|
|||||
Cost of hosting and professional services
|
$
|
5,541
|
|
|
$
|
6,957
|
|
Cost of product and licensing
|
129
|
|
|
264
|
|
||
Cost of maintenance and support
|
393
|
|
|
(234
|
)
|
||
Research and development
|
8,704
|
|
|
5,376
|
|
||
Sales and marketing
|
7,028
|
|
|
8,252
|
|
||
General and administrative
|
9,438
|
|
|
8,882
|
|
||
Total
|
$
|
31,233
|
|
|
$
|
29,497
|
|
|
Number of
Shares
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Remaining
Contractual
Term
|
|
Aggregate
Intrinsic
Value (a)
|
|||||
Outstanding at September 30, 2019
|
11,302
|
|
|
$
|
20.04
|
|
|
|
|
|
||
Exercised
|
(3,207
|
)
|
|
$
|
17.18
|
|
|
|
|
|
||
Expired
|
—
|
|
|
$
|
—
|
|
|
|
|
|
||
Equitable Adjustment - Cerence Spin-off (b)
|
1,883
|
|
|
|
|
|
|
|
||||
Outstanding at December 31, 2019
|
9,978
|
|
|
$
|
17.18
|
|
|
2.3 years
|
|
$
|
—
|
|
Exercisable at December 31, 2019
|
9,978
|
|
|
$
|
17.18
|
|
|
2.3 years
|
|
$
|
—
|
|
Exercisable at December 31, 2018
|
14,616
|
|
|
$
|
17.13
|
|
|
2.9 years
|
|
$
|
—
|
|
(a)
|
The aggregate intrinsic value in this table represents any excess of the closing market price of our common stock as of December 31, 2019 ($17.83) over the exercise price of the underlying options.
|
(b)
|
Effective with the spin-off of Automotive on October 1, 2019, outstanding equity awards were equitably adjusted by a conversion ratio of 1.16667 per one Nuance share then held.
|
|
Number of Shares Underlying Restricted Units — Performance-Based Awards
|
|
Number of Shares Underlying Restricted Units — Time-Based Awards
|
||
Outstanding at September 30, 2019
|
1,991,325
|
|
|
8,998,944
|
|
Granted
|
1,060,384
|
|
|
3,934,253
|
|
Earned/released
|
(303,198
|
)
|
|
(5,274,466
|
)
|
Forfeited
|
(418,834
|
)
|
|
(1,253,558
|
)
|
Equitable Adjustment - Cerence Spin-off (b)
|
303,074
|
|
|
1,316,006
|
|
Outstanding at December 31, 2019
|
2,632,751
|
|
|
7,721,179
|
|
Weighted average remaining recognition period of outstanding Restricted Units
|
2.1 years
|
|
|
1.9 years
|
|
Unrecognized stock-based compensation expense of outstanding Restricted Units
|
$27.2 million
|
|
$74.2 million
|
||
Aggregate intrinsic value of outstanding Restricted Units (a)
|
$46.9 million
|
|
$137.7 million
|
(a)
|
The aggregate intrinsic value in this table represents any excess of the closing market price of our common stock as of December 31, 2019 ($17.83) over the purchase price of the underlying restricted units.
|
(b)
|
Effective with the spin-off of Automotive on October 1, 2019, outstanding equity awards were equitably adjusted by a conversion ratio of 1.16667 per one Nuance share then held.
|
|
Three Months Ended December 31,
|
||||||
2019
|
|
2018
|
|||||
Weighted-average grant-date fair value per share
|
$
|
17.08
|
|
|
$
|
16.43
|
|
Total intrinsic value of shares vested (in millions)
|
$
|
95.4
|
|
|
$
|
82.4
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||
Dividend yield
|
0.0
|
%
|
|
0.0
|
%
|
Expected volatility
|
27.73
|
%
|
|
27.86% - 30.85%
|
|
Risk-free interest rate
|
1.62
|
%
|
|
2.72% - 3.02%
|
|
Expected term (in years)
|
3
|
|
|
1 - 3
|
|
|
Three Months Ended December 31,
|
||||||
2019
|
|
2018
|
|||||
Domestic
|
$
|
11,556
|
|
|
$
|
18,634
|
|
Foreign
|
6,881
|
|
|
(2,753
|
)
|
||
Income before income taxes
|
$
|
18,437
|
|
|
$
|
15,881
|
|
|
Three Months Ended December 31,
|
||||||
2019
|
|
2018
|
|||||
Domestic
|
$
|
(39,197
|
)
|
|
$
|
1,570
|
|
Foreign
|
2,757
|
|
|
430
|
|
||
(Benefit) provision for income taxes
|
$
|
(36,440
|
)
|
|
$
|
2,000
|
|
Effective tax rate
|
(197.6
|
)%
|
|
12.6
|
%
|
Fiscal Year
|
|
Operating Leases
|
|
Operating leases under restructuring
|
|
Total
|
||||||
2020
|
|
$
|
20,977
|
|
|
$
|
4,041
|
|
|
$
|
25,018
|
|
2021
|
|
23,918
|
|
|
3,147
|
|
|
27,065
|
|
|||
2022
|
|
19,384
|
|
|
2,866
|
|
|
22,250
|
|
|||
2023
|
|
13,400
|
|
|
2,939
|
|
|
16,339
|
|
|||
2024
|
|
11,471
|
|
|
1,629
|
|
|
13,100
|
|
|||
Thereafter
|
|
47,448
|
|
|
3,189
|
|
|
50,637
|
|
|||
Total
|
|
$
|
136,598
|
|
|
$
|
17,811
|
|
|
$
|
154,409
|
|
•
|
The Healthcare segment is primarily engaged in providing clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement.
|
•
|
The Enterprise segment is primarily engaged in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, web and messaging channels.
|
•
|
The Other segment includes voicemail transcription services, Mobile Operator Services, and our Devices business. In May 2019, we completed the sale of our Mobile Operator Services business in Brazil, and July 2019, we completed the sale of our Mobile Operator Services business in India.
|
|
Three Months Ended December 31,
|
||||||
|
2019
|
|
2018
|
||||
Segment revenues:
|
|
|
|
||||
Healthcare
|
$
|
270,534
|
|
|
$
|
271,978
|
|
Enterprise
|
138,473
|
|
|
129,692
|
|
||
Other
|
9,315
|
|
|
18,358
|
|
||
Total segment revenues
|
418,322
|
|
|
420,028
|
|
||
Less: acquisition-related revenues adjustments
|
(89
|
)
|
|
(353
|
)
|
||
Total revenues
|
418,233
|
|
|
419,675
|
|
||
Segment profit:
|
|
|
|
||||
Healthcare
|
93,279
|
|
|
102,556
|
|
||
Enterprise
|
42,536
|
|
|
42,282
|
|
||
Other
|
5,128
|
|
|
5,335
|
|
||
Total segment profit
|
140,943
|
|
|
150,173
|
|
||
Corporate expenses and other, net
|
(30,489
|
)
|
|
(35,114
|
)
|
||
Acquisition-related revenues
|
(89
|
)
|
|
(353
|
)
|
||
Stock-based compensation
|
(31,233
|
)
|
|
(29,497
|
)
|
||
Amortization of intangible assets
|
(19,176
|
)
|
|
(21,198
|
)
|
||
Acquisition-related costs, net
|
(1,167
|
)
|
|
(2,601
|
)
|
||
Restructuring and other charges, net
|
(6,683
|
)
|
|
(14,641
|
)
|
||
Other expenses, net
|
(33,669
|
)
|
|
(30,888
|
)
|
||
Income before income taxes
|
$
|
18,437
|
|
|
$
|
15,881
|
|
|
Three Months Ended December 31,
|
||||||
|
2019
|
|
2018
|
||||
United States
|
$
|
346,810
|
|
|
$
|
345,977
|
|
International
|
71,423
|
|
|
73,698
|
|
||
Total revenues
|
$
|
418,233
|
|
|
$
|
419,675
|
|
|
Three Months Ended December 31,
|
||||||
|
2019
|
|
2018
|
||||
|
(Dollars in thousands)
|
||||||
Interest paid
|
$
|
26,692
|
|
|
$
|
31,568
|
|
Income taxes paid
|
$
|
1,892
|
|
|
$
|
2,210
|
|
•
|
our future bookings, revenues, cost of revenues, research and development expenses, selling, general and administrative expenses, amortization of intangible assets and gross margin;
|
•
|
our strategy relating to our segments;
|
•
|
our programs to reduce costs and optimize processes;
|
•
|
market trends;
|
•
|
technological advancements;
|
•
|
the potential of future product releases;
|
•
|
our product development plans and the timing, amount and impact of investments in research and development;
|
•
|
future acquisitions, divestitures and other strategic transactions, and anticipated benefits from such transactions;
|
•
|
international operations and localized versions of our products; and
|
•
|
the conduct, timing and outcome of legal proceedings and litigation matters.
|
•
|
Healthcare. Our healthcare segment provides intelligent systems that support a more natural and insightful approach to clinical documentation, freeing clinicians to spend more time caring for patients and helping technicians and health organizations drive meaningful financial and clinical outcomes. Our principal solutions include dragon medical cloud based solutions ("Dragon Medical One"), computer assisted clinical documentation ("CAPD"), clinical documentation improvement ("CDI") and coding, diagnostic solutions, and medical transcription services.
|
•
|
Enterprise. Our Enterprise segment is a leading provider of AI-powered intelligent customer engagement solutions and services, which enable enterprises and contact centers to enhance and automate customer service and sales engagement. Our principal solutions include interactive voice responses ("IVR") solutions, intelligent engagement solutions and security & biometric solutions.
|
•
|
Other. Our Other segment includes voicemail transcription services, Mobile Operator Services, and our Devices business. In May 2019, we completed the sale of our Mobile Operator Services business in Brazil, and July 2019, we completed the sale of our Mobile Operator Services business in India.
|
•
|
Discontinued Operations. On February 1, 2019, we completed the sale of our Imaging business and received approximately $404.0 million in cash, after estimated transaction expenses. On October 1, 2019, we completed the previously announced spin-off of our Automotive business into an independent public company, Cerence. As a result, the historical results of operations for Imaging and Automotive have been included within discontinued operations in our condensed consolidated financial statements.
|
•
|
Total revenues were $418.2 million for the three months ended December 31, 2019, as compared to $419.7 million for the three months ended December 31, 2018;
|
•
|
Net income from continuing operations for the three months ended December 31, 2019 was $54.9 million, compared to net income from continuing operations of $13.9 million for the three months ended December 31, 2018;
|
•
|
Gross margins for the three months ended December 31, 2019 were 55.9%, compared to 56.1% for the three months ended December 31, 2018;
|
•
|
Operating margins for the three months ended December 31, 2019 was 12.5%, compared to 11.1% for three months ended December 31, 2018; and
|
•
|
Operating cash flows from continuing operations decreased by $5.8 million to $66.9 million for the three months ended December 31, 2019, compared to $72.7 million for the three months ended December 31, 2018.
|
|
|
Three Months Ended December 31,
|
|
Dollar
Change
|
|
Percent
Change
|
|||||||||
2019
|
|
2018
|
|
|
|||||||||||
Hosting and professional services
|
|
$
|
230.5
|
|
|
$
|
227.7
|
|
|
$
|
2.8
|
|
|
1.2
|
%
|
Product and licensing
|
|
125.2
|
|
|
115.9
|
|
|
9.3
|
|
|
8.0
|
%
|
|||
Maintenance and support
|
|
62.6
|
|
|
76.1
|
|
|
(13.5
|
)
|
|
(17.7
|
)%
|
|||
Total revenues
|
|
$
|
418.2
|
|
|
$
|
419.7
|
|
|
$
|
(1.5
|
)
|
|
(0.4
|
)%
|
|
|
|
|
|
|
|
|
|
|||||||
United States
|
|
$
|
346.8
|
|
|
$
|
346.0
|
|
|
$
|
0.8
|
|
|
0.2
|
%
|
International
|
|
71.4
|
|
|
73.7
|
|
|
(2.3
|
)
|
|
(3.1
|
)%
|
|||
Total revenues
|
|
$
|
418.2
|
|
|
$
|
419.7
|
|
|
$
|
(1.5
|
)
|
|
(0.4
|
)%
|
|
|
|
Three Months Ended December 31,
|
|
Dollar
Change |
|
Percent
Change |
|||||||||
2019
|
|
2018
|
|
|
|||||||||||
Hosting revenue
|
|
$
|
195.0
|
|
|
$
|
186.7
|
|
|
$
|
8.3
|
|
|
4.4
|
%
|
Professional services revenue
|
|
35.5
|
|
|
41.1
|
|
|
(5.5
|
)
|
|
(13.4
|
)%
|
|||
Hosting and professional services revenue
|
|
$
|
230.5
|
|
|
$
|
227.7
|
|
|
$
|
2.8
|
|
|
1.2
|
%
|
As a percentage of total revenue
|
|
55.1
|
%
|
|
54.3
|
%
|
|
|
|
|
|
|
|
|
Three Months Ended December 31,
|
|
Dollar
Change |
|
Percent
Change |
|||||||||
2019
|
|
2018
|
|
|
|||||||||||
Product and licensing revenue
|
|
$
|
125.2
|
|
|
$
|
115.9
|
|
|
$
|
9.3
|
|
|
8.0
|
%
|
As a percentage of total revenue
|
|
29.9
|
%
|
|
27.6
|
%
|
|
|
|
|
|
|
Three Months Ended December 31,
|
|
Dollar
Change |
|
Percent
Change |
|||||||||
2019
|
|
2018
|
|
|
|||||||||||
Maintenance and support revenue
|
|
$
|
62.6
|
|
|
$
|
76.1
|
|
|
$
|
(13.5
|
)
|
|
(17.7
|
)%
|
As a percentage of total revenue
|
|
15.0
|
%
|
|
18.1
|
%
|
|
|
|
|
|
|
Three Months Ended December 31,
|
|
Dollar
Change |
|
Percent
Change |
|||||||||
2019
|
|
2018
|
|
|
|||||||||||
Cost of hosting and professional services revenue
|
|
$
|
135.8
|
|
|
$
|
136.6
|
|
|
$
|
(0.8
|
)
|
|
(0.6
|
)%
|
As a percentage of professional services and hosting revenue
|
|
58.9
|
%
|
|
60.0
|
%
|
|
|
|
|
|
|
Three Months Ended December 31,
|
|
Dollar
Change |
|
Percent
Change |
|||||||||
2019
|
|
2018
|
|
|
|||||||||||
Cost of product and licensing revenue
|
|
$
|
34.2
|
|
|
$
|
32.4
|
|
|
$
|
1.8
|
|
|
5.6
|
%
|
As a percentage of product and licensing revenue
|
|
27.3
|
%
|
|
28.0
|
%
|
|
|
|
|
|
|
Three Months Ended December 31,
|
|
Dollar
Change |
|
Percent
Change |
|||||||||
2019
|
|
2018
|
|
|
|||||||||||
Cost of maintenance and support revenue
|
|
$
|
7.8
|
|
|
$
|
7.8
|
|
|
$
|
—
|
|
|
—
|
%
|
As a percentage of maintenance and support revenue
|
|
12.5
|
%
|
|
10.2
|
%
|
|
|
|
|
|
|
Three Months Ended December 31,
|
|
Dollar
Change |
|
Percent
Change |
|||||||||
2019
|
|
2018
|
|
|
|||||||||||
Research and development expense
|
|
$
|
56.6
|
|
|
$
|
46.9
|
|
|
$
|
9.7
|
|
|
20.7
|
%
|
As a percentage of total revenue
|
|
13.5
|
%
|
|
11.2
|
%
|
|
|
|
|
|
|
Three Months Ended December 31,
|
|
Dollar
Change |
|
Percent
Change |
|||||||||
2019
|
|
2018
|
|
|
|||||||||||
Sales and marketing expense
|
|
$
|
66.5
|
|
|
$
|
67.4
|
|
|
$
|
(0.9
|
)
|
|
(1.3
|
)%
|
As a percentage of total revenue
|
|
15.9
|
%
|
|
16.1
|
%
|
|
|
|
|
|
|
Three Months Ended December 31,
|
|
Dollar
Change
|
|
Percent
Change
|
|||||||||
2019
|
|
2018
|
|
|
|||||||||||
General and administrative expense
|
|
$
|
38.3
|
|
|
$
|
43.5
|
|
|
$
|
(5.2
|
)
|
|
(12.0
|
)%
|
As a percentage of total revenue
|
|
9.2
|
%
|
|
10.4
|
%
|
|
|
|
|
|
Three Months Ended December 31,
|
|
Dollar
Change
|
|
Percent
Change
|
|||||||||
2019
|
|
2018
|
|
|||||||||||
Cost of revenue
|
$
|
6.6
|
|
|
$
|
7.4
|
|
|
$
|
(0.7
|
)
|
|
(9.9
|
)%
|
Operating expenses
|
12.5
|
|
|
13.8
|
|
|
(1.3
|
)
|
|
(9.3
|
)%
|
|||
Total amortization expense
|
$
|
19.2
|
|
|
$
|
21.2
|
|
|
$
|
(2.0
|
)
|
|
(9.5
|
)%
|
|
Three Months Ended December 31,
|
|
Dollar
Change
|
|
Percent
Change
|
|||||||||
2019
|
|
2018
|
|
|||||||||||
Transition and integration costs
|
$
|
1.5
|
|
|
$
|
2.7
|
|
|
$
|
(1.2
|
)
|
|
(45.3
|
)%
|
Professional service fees
|
(0.3
|
)
|
|
—
|
|
|
(0.3
|
)
|
|
(708.5
|
)%
|
|||
Acquisition-related adjustments
|
—
|
|
|
(0.1
|
)
|
|
0.1
|
|
|
(98.1
|
)%
|
|||
Total acquisition-related costs, net
|
$
|
1.2
|
|
|
$
|
2.6
|
|
|
$
|
(1.4
|
)
|
|
(55.1
|
)%
|
|
Three Months Ended December 31,
|
||||||||||||||||||||||||||||||||||||||
|
2019
|
|
2018
|
||||||||||||||||||||||||||||||||||||
|
Personnel
|
|
Facilities
|
|
Total Restructuring
|
|
Other Charges
|
|
Total
|
|
Personnel
|
|
Facilities
|
|
Total Restructuring
|
|
Other Charges
|
|
Total
|
||||||||||||||||||||
Healthcare
|
$
|
1,276
|
|
|
$
|
1,527
|
|
|
$
|
2,803
|
|
|
$
|
—
|
|
|
$
|
2,803
|
|
|
$
|
1,479
|
|
|
$
|
127
|
|
|
$
|
1,606
|
|
|
$
|
—
|
|
|
$
|
1,606
|
|
Enterprise
|
1,304
|
|
|
505
|
|
|
1,809
|
|
|
—
|
|
|
1,809
|
|
|
2,551
|
|
|
13
|
|
|
2,564
|
|
|
—
|
|
|
2,564
|
|
||||||||||
Other
|
—
|
|
|
(365
|
)
|
|
(365
|
)
|
|
—
|
|
|
(365
|
)
|
|
1,030
|
|
|
—
|
|
|
1,030
|
|
|
2,507
|
|
|
3,537
|
|
||||||||||
Corporate
|
333
|
|
|
(532
|
)
|
|
(199
|
)
|
|
2,635
|
|
|
2,436
|
|
|
1,153
|
|
|
(290
|
)
|
|
863
|
|
|
6,071
|
|
|
6,934
|
|
||||||||||
Total
|
$
|
2,913
|
|
|
$
|
1,135
|
|
|
$
|
4,048
|
|
|
$
|
2,635
|
|
|
$
|
6,683
|
|
|
$
|
6,213
|
|
|
$
|
(150
|
)
|
|
$
|
6,063
|
|
|
$
|
8,578
|
|
|
$
|
14,641
|
|
|
|
Three Months Ended December 31,
|
|
Dollar
Change
|
|
Percent
Change
|
|||||||||
2019
|
|
2018
|
|
|||||||||||
Interest income
|
$
|
2.2
|
|
|
$
|
2.6
|
|
|
$
|
(0.4
|
)
|
|
(14.4
|
)%
|
Interest expense
|
(23.8
|
)
|
|
(32.3
|
)
|
|
8.5
|
|
|
(26.2
|
)%
|
|||
Other expense, net
|
(12.0
|
)
|
|
(1.2
|
)
|
|
(10.9
|
)
|
|
923.8
|
%
|
|||
Total other expense, net
|
$
|
(33.7
|
)
|
|
$
|
(30.9
|
)
|
|
$
|
(2.8
|
)
|
|
9.0
|
%
|
|
Three Months Ended December 31,
|
|
Dollar
Change
|
|
Percent
Change
|
|||||||||
2019
|
|
2018
|
|
|||||||||||
(Benefit) provision for income taxes
|
$
|
(36.4
|
)
|
|
$
|
2.0
|
|
|
$
|
(38.4
|
)
|
|
(1,922.0
|
)%
|
Effective income tax rate
|
(197.6
|
)%
|
|
12.6
|
%
|
|
|
|
|
|
Three Months Ended December 31,
|
|
Change
|
|
Percent
Change |
|||||||||
2019
|
|
2018
|
|
|
||||||||||
Segment Revenues(a):
|
|
|
|
|
|
|
|
|||||||
Healthcare
|
$
|
270.5
|
|
|
$
|
272.0
|
|
|
$
|
(1.4
|
)
|
|
(0.5
|
)%
|
Enterprise
|
138.5
|
|
|
129.7
|
|
|
8.8
|
|
|
6.8
|
%
|
|||
Other
|
9.3
|
|
|
18.4
|
|
|
(9.0
|
)
|
|
(49.3
|
)%
|
|||
Total segment revenues
|
$
|
418.3
|
|
|
$
|
420.0
|
|
|
$
|
(1.7
|
)
|
|
(0.4
|
)%
|
Less: acquisition related revenues adjustments
|
(0.1
|
)
|
|
(0.4
|
)
|
|
0.3
|
|
|
(74.8
|
)%
|
|||
Total revenues
|
$
|
418.2
|
|
|
$
|
419.7
|
|
|
$
|
(1.5
|
)
|
|
(0.4
|
)%
|
Segment Profit:
|
|
|
|
|
|
|
|
|||||||
Healthcare
|
$
|
93.3
|
|
|
$
|
102.6
|
|
|
$
|
(9.3
|
)
|
|
(9.0
|
)%
|
Enterprise
|
42.5
|
|
|
42.3
|
|
|
0.2
|
|
|
0.6
|
%
|
|||
Other
|
5.1
|
|
|
5.3
|
|
|
(0.2
|
)
|
|
(3.9
|
)%
|
|||
Total segment profit
|
$
|
140.9
|
|
|
$
|
150.2
|
|
|
$
|
(9.3
|
)
|
|
(6.2
|
)%
|
Segment Profit Margin:
|
|
|
|
|
|
|
|
|||||||
Healthcare
|
34.5
|
%
|
|
37.7
|
%
|
|
(3.2
|
)
|
|
|
||||
Enterprise
|
30.7
|
%
|
|
32.6
|
%
|
|
(1.9
|
)
|
|
|
||||
Other
|
55.1
|
%
|
|
29.1
|
%
|
|
26.0
|
|
|
|
||||
Total segment profit margin
|
33.7
|
%
|
|
35.8
|
%
|
|
(2.1
|
)
|
|
|
|
(a)
|
Segment revenues differ from reported revenues due to certain revenue adjustments related to acquisitions that would otherwise have been recognized but for the purchase accounting treatment of the business combinations. These revenues are included to allow for more complete comparisons to the financial results of historical operations and in evaluating management performance.
|
•
|
Healthcare segment revenue, for the three months ended December 31, 2019, decreased by $1.4 million, or 0.5%, primarily driven by:
|
◦
|
Revenue from Dragon Medical cloud-based solutions increased by $22.3 million, or 51.2%, to $65.8 million for the three months ended December 31, 2019 from $43.5 million for the three months ended December 31, 2018, primarily due to the continued market penetration and customer transition to our cloud-based offering.
|
◦
|
Revenue from transcription services decreased by $8.3 million, or 14.6%, to $48.8 million for the three months ended December 31, 2019 from $57.1 million for the three months ended December 31, 2018.
|
◦
|
Revenue from Dragon Medical licensing and maintenance and support decreased by $13.2 million, or 39.9%, to $19.8 million for the three months ended December 31, 2019 from $33.0 million for the three months ended December 31, 2018, primarily driven by the continued transition from software sold with maintenance and support to cloud-based solutions.
|
◦
|
Professional services revenue decreased by $0.8 million or 5.1%, to $15.6 million for the three months ended December 31, 2019 from $16.4 million for the three months ended December 31, 2018, primarily driven by lower revenue from EHR implementation and optimization services.
|
•
|
Enterprise segment revenue, for the three months ended December 31, 2019, increased by $8.8 million, or 6.8%, primarily due to the increases in our IVR and security and biometrics solutions.
|
•
|
Other segment revenue, for the three months ended December 31, 2019, decreased by $9.0 million, or 49.3%, primarily due to the wind-down of Devices and the sale of Mobile Operator Services business in Brazil in fiscal year 2019.
|
•
|
Healthcare segment profit, for the three months ended December 31, 2019, decreased by $9.3 million, or 9.0%, primarily due to slightly lower revenue on relatively flat margin, and higher R&D and sales & marking expenses. The increase in R&D and sales and marketing expenses was primarily due to higher spend to support the development and sale of new products and solutions. As a result, segment profit margin declined by 3.2 percentage points to 34.5%.
|
•
|
Enterprise segment profit, for the three months ended December 31, 2019, increased by $0.3 million, or 0.6%, primarily due to higher segment revenue, mostly offset by lower gross margin and higher R&D expenses. Gross margin decline was primarily due to higher digital hosting costs. The increase in R&D expenses was primarily due to higher spend on core technology to support future growth. As a result, segment profit margin declined by 1.9 percentage points to 30.7%.
|
•
|
Other segment profit, for the three months ended December 31, 2019, decreased by $0.2 million, or 3.9%, primarily driven by lower revenue, offset by lower expense profile of the remaining business. Lower revenue was primarily due to the wind-down of Devices and the sale of Mobile Operator Services business in Brazil in fiscal year 2019. As a result, segment profit margin improved by 26.0% percentage points to 55.1%.
|
•
|
A decrease of $14.2 million in cash provided due to unfavorable changes in working capital, primarily due to the timing of cash collections and cash payments;
|
•
|
A decrease of $5.0 million in cash provided from changes in deferred revenue. Deferred revenue had a positive effect of $26.9 million on operating cash flows for the three months ended December 31, 2019, as compared to $31.9 million for the three months ended December 31, 2018;
|
•
|
A decrease of $40.5 million in cash provided from operating cash flows from discontinued operations; offset in part by,
|
•
|
An increase of $13.4 million in cash provided due to higher income before non-cash charges.
|
•
|
An increase of $2.0 million in cash used for capital expenditures;
|
•
|
An increase of $2.3 million in cash used for the net proceeds from the sale and purchase of marketable securities and other investments; offset in part by,
|
•
|
A decrease of $2.7 million in cash used in other investing activities.
|
•
|
An increase of $313.5 million in cash used for the repayment and redemption of debt;
|
•
|
An increase of $17.3 million in cash used for share repurchases; offset in part by,
|
•
|
A net contribution of $139.1 million from Cerence in connection with the spin-off of the Automotive segment; and
|
•
|
A decrease of $1.7 million in cash used for payments for taxes related to net share settlement of equity awards.
|
|
|
Contractual Payments Due in Fiscal Year
|
||||||||||||||||||
Contractual Obligations
|
|
Total
|
|
2020
|
|
2021 and 2022
|
|
2023 and 2024
|
|
Thereafter
|
||||||||||
Convertible debentures(1)
|
|
$
|
1,337.0
|
|
|
$
|
—
|
|
|
$
|
310.5
|
|
|
$
|
676.5
|
|
|
$
|
350.0
|
|
Senior notes(2)
|
|
500.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
500.0
|
|
|||||
Interest payable on long-term debt(3)
|
|
236.3
|
|
|
22.3
|
|
|
84.2
|
|
|
66.7
|
|
|
63.1
|
|
|||||
Letters of credit(4)
|
|
5.9
|
|
|
5.9
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Lease obligations and other liabilities:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Operating leases(5)
|
|
136.6
|
|
|
21.0
|
|
|
43.3
|
|
|
24.9
|
|
|
47.4
|
|
|||||
Operating leases under restructuring
|
|
17.8
|
|
|
4.0
|
|
|
6.0
|
|
|
4.6
|
|
|
3.2
|
|
|||||
Purchase commitments for inventory, property and equipment(6)
|
|
194.3
|
|
|
52.9
|
|
|
100.7
|
|
|
40.7
|
|
|
—
|
|
|||||
Total contractual cash obligations
|
|
$
|
2,427.9
|
|
|
$
|
106.1
|
|
|
$
|
544.7
|
|
|
$
|
813.4
|
|
|
$
|
963.7
|
|
(1)
|
Pursuant to the terms of each convertible instrument, holders have the right to redeem the debt on specific dates prior to maturity. The repayment schedule above assumes that payment is due on the next redemption date after December 31, 2019.
|
(2)
|
The repayment schedule reflects all the senior notes outstanding as of December 31, 2019.
|
(3)
|
Interest per annum is due and payable semi-annually and is determined based on the outstanding principal as of December 31, 2019, the stated interest rate of each debt instrument and the assumed redemption dates discussed above.
|
(4)
|
Letters of credit are in place primarily to secure future operating lease payments.
|
(5)
|
Obligations include contractual lease commitments related to facilities that have subsequently been subleased. As of December 31, 2019, we have subleased certain facilities with total sublease income of $14.2 million through fiscal year 2027.
|
(6)
|
These amounts include non-cancelable purchase commitments for property and equipment as well as inventory in the normal course of business to fulfill customer backlog.
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
|
December 31, 2019
|
||||||||||||||
|
Fair value
|
|
Conversion value
|
|
Increase to fair value
|
|
Increase to conversion value
|
||||||||
2.75% 2031 Debentures
|
$
|
46.1
|
|
|
$
|
29.0
|
|
|
$
|
0.2
|
|
|
$
|
2.9
|
|
1.5% 2035 Debentures
|
$
|
279.4
|
|
|
$
|
228.3
|
|
|
$
|
9.8
|
|
|
$
|
22.8
|
|
1.0% 2035 Debentures
|
$
|
677.7
|
|
|
$
|
500.1
|
|
|
$
|
20.5
|
|
|
$
|
50.0
|
|
1.25% 2025 Debentures
|
$
|
388.8
|
|
|
$
|
317.0
|
|
|
$
|
20.8
|
|
|
$
|
31.7
|
|
Item 4.
|
Controls and Procedures
|
Period
|
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Program (1)
|
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(1)
|
|||
October 1, 2019 - October 31, 2019
|
|
3,290,344
|
|
|
15.20
|
|
|
3,290,344
|
|
|
$380.4 million
|
November 1, 2019 - November 30, 2019
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$380.4 million
|
December 1, 2019 - December 31, 2019
|
|
2,403,198
|
|
|
17.66
|
|
|
2,403,198
|
|
|
$337.9 million
|
Total
|
|
5,693,542
|
|
|
|
|
5,693,542
|
|
|
|
Item 3.
|
Defaults Upon Senior Securities
|
Item 4.
|
Mine Safety Disclosures
|
Item 5.
|
Other Information
|
Item 6.
|
Exhibits
|
|
|
|
|
Incorporated by Reference
|
||||||||
Exhibit
Number
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing
Date
|
|
Filed
Herewith
|
3.1
|
|
|
10-Q
|
|
0-27038
|
|
3.2
|
|
5/11/2001
|
|
|
|
3.2
|
|
|
10-Q
|
|
0-27038
|
|
3.1
|
|
8/9/2004
|
|
|
|
3.3
|
|
|
8-K
|
|
0-27038
|
|
3.1
|
|
10/19/2005
|
|
|
|
3.4
|
|
|
S-3
|
|
333-142182
|
|
3.3
|
|
4/18/2007
|
|
|
|
3.5
|
|
|
10-K
|
|
1-36056
|
|
3.4
|
|
11/7/2019
|
|
|
|
10.1
|
|
|
|
|
|
|
|
|
|
|
|
X
|
10.2
|
|
|
|
|
|
|
|
|
|
|
X
|
|
31.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
31.2
|
|
|
|
|
|
|
|
|
|
|
X
|
|
32.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
101
|
|
The following materials from Nuance Communications, Inc.’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2019, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Statements of Comprehensive Loss, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows, and (v) Notes to Unaudited Condensed Consolidated Financial Statements.
|
|
|
|
|
|
|
|
|
|
X
|
104
|
|
The cover page of the Quarterly Report on Form 10-Q for the quarter ended December 31, 2019 formatted in Inline XBRL (included in Exhibit 101)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nuance Communications, Inc.
|
||
|
|
|
|
|
By:
|
|
/s/ Daniel D. Tempesta
|
|
|
|
Daniel D. Tempesta
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
|
|
Name:
|
[•]
|
Number of Restricted Stock Units subject to Award:
|
[•]
|
Date of Grant:
|
[•]
|
1.
|
Grant of Restricted Stock Unit Award. The Company grants to the Participant on the date set forth above (the “Date of Grant”) the number of restricted stock units (the “RSUs”) set forth above giving the Participant the conditional right to receive, without payment and pursuant to and subject to the terms and conditions set forth in this Agreement and in the Plan, one share of Stock (a “Share”) with respect to each RSU forming part of the Award, subject to adjustment pursuant to Section 8 of the Plan in respect of transactions occurring after the date hereof.
|
Number of RSUs
|
Vesting Date
|
[•]
|
[•]
|
[•]
|
[•]
|
[•]
|
[•]
|
[•]
|
[•]
|
[•]
|
[•]
|
[•]
|
[•]
|
[•]
|
[•]
|
Name:
|
[•]
|
Number of Target PSUs subject to Award:
|
[•]
|
Date of Grant:
|
[•]
|
1.
|
Grant of Performance-Based Restricted Stock Unit Award. The Company grants to the Participant on the date set forth above (the “Date of Grant”) an Award consisting of a target number of performance-based restricted stock units (the “Target Award” and such performance-based restricted stock units, the “PSUs”) set forth above giving the Participant the conditional right to receive, without payment and pursuant to and subject to the terms and conditions set forth in this Agreement and in the Plan, one share of Stock (a “Share”) with respect to each PSU forming part of the Award, subject to adjustment pursuant to Section 8 of the Plan in respect of transactions occurring after the date hereof. The percentage of the Target Award that may be earned by the Participant will be determined in accordance with Exhibit A hereto.
|
a.
|
“Performance Period” shall mean [ ].
|
b.
|
“Vesting Date” shall mean [ ].
|
a.
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
a.
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
By:
|
|
/s/ Mark Benjamin
|
|
|
|
Mark Benjamin
|
|
|
|
Chief Executive Officer
|
a.
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
a.
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
By:
|
|
/s/ Daniel D. Tempesta
|
|
|
|
Daniel D. Tempesta
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
By:
|
|
/s/ Mark Benjamin
|
|
|
|
Mark Benjamin
|
|
|
|
Chief Executive Officer
|
|
By:
|
|
/s/ Daniel D. Tempesta
|
|
|
|
Daniel D. Tempesta
|
|
|
|
Executive Vice President and Chief Financial Officer
|